Tokyo, Japan and London, UK, 10 May 2018 – Sosei Group Corporation (“Sosei” or the “Company”; TSE Mothers Index: 4565), the world leader in GPCR medicine design and development, announced that at a meeting of the Board of Directors held today, it resolved to conduct a stock split and partially revise the Articles of Incorporation.
2.3. Adjustment of Exercise Price of Stock Option In connection with the announced stock split, the exercise price of stock acquisition rights shall be adjusted as follows after the record date.